These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Does ICD therapy benefit women with a history of myocardial infarction and severe left ventricular dysfunction? Al-Khatib SM J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1271-2. PubMed ID: 16403054 [No Abstract] [Full Text] [Related]
29. Pacing in heart failure patients with narrow QRS: is there more to gain than resynchronization? Smiseth OA; Russell K; Remme EW Circulation; 2009 Oct; 120(17):1651-3. PubMed ID: 19822804 [No Abstract] [Full Text] [Related]
31. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator. Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756 [TBL] [Abstract][Full Text] [Related]
32. Palpitations in a cardiac resynchronization therapy recipient: what's the mechanism? Badran H; Semmler V; Kolb C Pacing Clin Electrophysiol; 2012 Aug; 35(8):1018-20. PubMed ID: 22353038 [No Abstract] [Full Text] [Related]
33. Does everyone with left ventricular dysfunction need an ICD?: Lessons learned from left ventricular noncompaction. Santangeli P; Dello Russo A; Casella M Pacing Clin Electrophysiol; 2008 Aug; 31(8):1085; author reply 1085-6. PubMed ID: 18684273 [No Abstract] [Full Text] [Related]
34. Device therapies in the post-myocardial infarction patient with left ventricular dysfunction. Kadish AH; Reiffel JA; Naccarelli GV; DiMarco JP Am J Cardiol; 2008 Sep; 102(5A):29G-37G. PubMed ID: 18722189 [TBL] [Abstract][Full Text] [Related]
35. Association between decreased intra-thoracic impedance and ventricular tachyarrhythmias. Andriulli J; Coles J; Hettrick DA Int J Cardiol; 2008 Jan; 123(3):333-4. PubMed ID: 17343933 [No Abstract] [Full Text] [Related]
36. Implantable cardioverter defibrillator therapy: ten years experience in a medical center. Chen TE; Wang CC; Chang SH; Yeh SJ; Wu D Chang Gung Med J; 2008; 31(1):81-90. PubMed ID: 18419057 [TBL] [Abstract][Full Text] [Related]
37. Cardiac devices and neuromuscular disorders in left ventricular noncompaction. Stöllberger C; Keller H; Blazek G; Bichler K; Wegner C; Finsterer J Int J Cardiol; 2011 Apr; 148(1):120-3. PubMed ID: 21334754 [No Abstract] [Full Text] [Related]
38. Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: the InSync ICD (Implantable Cardioverter-Defibrillator) Italian Registry. Di Biase L; Gasparini M; Lunati M; Santini M; Landolina M; Boriani G; Curnis A; Bocchiardo M; Vincenti A; Denaro A; Valsecchi S; Natale A; Padeletti L; J Am Coll Cardiol; 2008 Oct; 52(18):1442-9. PubMed ID: 19017510 [TBL] [Abstract][Full Text] [Related]
39. Worsening heart failure and recurrent untreated ventricular tachycardia in a CRT-D treated patient: why? Jefic D; Zein AM; Johnson KM; Pires LA Pacing Clin Electrophysiol; 2007 Oct; 30(10):1276-8. PubMed ID: 17897132 [No Abstract] [Full Text] [Related]